Study title: A double-blind, crossover trial comparing "Tilade" (Nedocromil sodium) 4 mg three times daily and "INTAL" (Sodium cromoglycate) 4 mg three times daily in the management of children with bronchial asthma, currently being treated with "INTAL", 2 mg three times daily but responding at a sub-optimal level - C. Mellis - 1990 - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 -
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: NEDOCROMIL | |||||
ATC code: S01GX04 | |||||
Document link: | |||||
Document date: 2013-01-24 | |||||
Study number: CR 1879 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |